EM1604L "Molecular Genetics in the Diagnosis and Management of Thyroid Cancer" (IM GR042916)
Discuss clinical controversies in the diagnosis and management of thyroid cancers, including the overdiagnosis and overtreatment of indolent forms of thyroid cancer and the development of re-differentiation strategies for radioiodine-refractory advanced thyroid cancer.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Review the spectrum of disease phenotypes for follicular cell derived thyroid cancers
- Understand the somatic genetics of common forms of thyroid cancer
- Present evidence supporting the current overdiagnosis and overtreatment of thyroid cancer
- Discuss potential strategies to minimize overtreatment of indolent forms of thyroid cancer
- Describe new approaches promoting the re-sensitization of radioiodine-refractory thyroid cancers to iodine-based therapies
David G. McFadden, M.D., Ph.D.
Departments of Internal Medicine and Biochemistry
Division of Endocrinology
- 1.00 AMA
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome